ES2058361T3 - Procedimiento para la preparacion de una matriz de fase solida. - Google Patents

Procedimiento para la preparacion de una matriz de fase solida.

Info

Publication number
ES2058361T3
ES2058361T3 ES89103528T ES89103528T ES2058361T3 ES 2058361 T3 ES2058361 T3 ES 2058361T3 ES 89103528 T ES89103528 T ES 89103528T ES 89103528 T ES89103528 T ES 89103528T ES 2058361 T3 ES2058361 T3 ES 2058361T3
Authority
ES
Spain
Prior art keywords
couples
polymerized
procedure
preparation
solid phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89103528T
Other languages
English (en)
Spanish (es)
Inventor
Michael Dr Berger
Arno Dr Deger
Josef Maier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2058361T3 publication Critical patent/ES2058361T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Ceramic Products (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
ES89103528T 1988-02-29 1989-02-28 Procedimiento para la preparacion de una matriz de fase solida. Expired - Lifetime ES2058361T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3806431A DE3806431A1 (de) 1988-02-29 1988-02-29 Verfahren zur herstellung einer festphasenmatrix

Publications (1)

Publication Number Publication Date
ES2058361T3 true ES2058361T3 (es) 1994-11-01

Family

ID=6348450

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89103528T Expired - Lifetime ES2058361T3 (es) 1988-02-29 1989-02-28 Procedimiento para la preparacion de una matriz de fase solida.

Country Status (8)

Country Link
EP (1) EP0331127B1 (OSRAM)
JP (1) JPH0830705B2 (OSRAM)
AT (1) ATE90790T1 (OSRAM)
CA (1) CA1335265C (OSRAM)
DE (2) DE3806431A1 (OSRAM)
ES (1) ES2058361T3 (OSRAM)
GR (1) GR3009564T3 (OSRAM)
WO (1) WO1989008259A1 (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0488152A3 (en) * 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
DE4041080A1 (de) 1990-12-21 1992-06-25 Behringwerke Ag Verfahren zur bestimmung eines analyten
WO1994006345A2 (en) * 1992-09-11 1994-03-31 Dambinova Svetlana Alexandrovn Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
EP0699906B1 (de) 1994-07-25 2002-04-24 Roche Diagnostics GmbH Verfahren zum Nachweis der Kontamination einer Oberfläche mit einem Analyten
DE4434093A1 (de) * 1994-09-23 1996-03-28 Boehringer Mannheim Gmbh Verfahren zum qualitativen oder/und quantitativen Nachweis einer zu bestimmenden Substanz
DE19709090A1 (de) * 1997-03-06 1998-09-10 Boehringer Mannheim Gmbh Analytisches Testelement mit flüssigkeitsgefüllten Blister
DE19724787A1 (de) * 1997-06-06 1998-12-10 Biotez Berlin Buch Gmbh Bioche Streptavidin/Avidin beschichtete Oberflächen
WO2000066770A2 (de) * 1999-05-03 2000-11-09 Biotez Berlin-Buch Gmbh Verfahren zur herstellung einer chemo- und thermostabilen festphasenmatrix für polymerase chain reaction (pcr) und dna-hybridisierungsassay
DE19927783A1 (de) 1999-06-18 2000-12-21 Roche Diagnostics Gmbh Element zur Bestimmung eines Analyts in einer Flüssigkeit, entsprechendes Bestimmungsverfahren unter Verwendung des Elementes sowie Kit zur Bestimmugn eines Analyts
US20230322996A1 (en) 2021-11-08 2023-10-12 Life Technologies As Polymer-interaction molecule conjugates and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230685A (en) * 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4282287A (en) * 1980-01-24 1981-08-04 Giese Roger W Biochemical avidin-biotin multiple-layer system
US4478946A (en) * 1981-07-02 1984-10-23 South African Inventions Development Corporation Carrier bound immunosorbent
FR2543972B1 (fr) * 1983-04-06 1985-12-27 Immunotech Sa Procede de fixation de macromolecules biologiques sur des supports
DE3446636A1 (de) * 1984-12-20 1986-06-26 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung eines immunreaktiven poroesen traegermaterials
AU7032787A (en) * 1986-02-06 1987-08-25 Microbiological Associates, Inc. Latex agglutination using avidin/biotin system
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
DE3640412A1 (de) * 1986-11-26 1988-06-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung einer spezifisch bindefaehigen substanz

Also Published As

Publication number Publication date
JPH02500687A (ja) 1990-03-08
DE3806431A1 (de) 1989-09-07
JPH0830705B2 (ja) 1996-03-27
WO1989008259A1 (fr) 1989-09-08
GR3009564T3 (OSRAM) 1994-02-28
CA1335265C (en) 1995-04-18
DE58904672D1 (de) 1993-07-22
EP0331127B1 (de) 1993-06-16
EP0331127A1 (de) 1989-09-06
ATE90790T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
ES2058361T3 (es) Procedimiento para la preparacion de una matriz de fase solida.
Vacquier et al. Protease activity establishes the block against polyspermy in sea urchin eggs
Monks et al. Reactive intermediates and their toxicological significance
ES2060603T3 (es) El uso de la proteina vp6 nucleocapsida de rotavirus en composiciones de vacunas.
DE59106279D1 (de) Neue protein-polykation-konjugate.
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
ES2081307T3 (es) Procedimiento para secar celulas de mamifero para uso en inmunoensayos en fase solida y articulos a los que estan incorporados.
DK1187928T3 (da) Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics
CA2056279A1 (en) Cell-free receptor binding assays, the production and use thereof
FI902143A7 (fi) HIV-peptidit, keinotekoiset HIV-antigeenit ja immunomäärityspakkaukset
RU94024566A (ru) Способ модификации, способ обеспечения связывания белка с антителом, фармацевтические композиции, способ диагностики
ES2078923T3 (es) Inmunoensayo enzimatico para detectar los antigenos y fase solida para su realizacion.
FI893428A7 (fi) TNF-a:n in vitro ja in vivo toksisten ominaisuuksien eliminointi monoklonaalisilla vasta-aineilla ja niistä johdetuilla fragmenteilla
DE69119810D1 (de) Pyrogensorbentmittel
ATE193022T1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
ES2067544T3 (es) Membranas de afinidad que tienen grupos hidroxilo pendientes y procesos para la preparacion y uso de las mismas.
ES2062394T3 (es) Medio que contiene un ligando para la separacion cromatografica, procedimiento para la preparacion del medio y uso del medio para aislar moleculas naturales o sinteticas de una mezcla liquida.
DK258789A (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
ES469641A1 (es) Procedimiento para la determinacion de hormonas y farmacos no ligados
FI102834B1 (fi) Kysteiinitioli-suojatut peptidit käytettäviksi immunologisissa määrityksissä
ATE130311T1 (de) Mehrfache festphasensynthese von peptiden.
DE3789041D1 (de) Reagenz für Beseitigung von Schutzgruppen in peptidischer Synthese.
GR900100550A (el) Μία μέ?οδος για την αναστολή της αντιγραφής ιού σε κύτταρα ?ηλαστικών χρησιμοποιώντας συζυγείς πρωτεϊνης αντιιού φυτολάκκας - μονοκλωνικού αντισώματος.
ES380066A2 (es) Un metodo para obtener un preparado de eritrocitos estabi- lizados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 331127

Country of ref document: ES